Dosing regimen

TW202637184APending Publication Date: 2026-09-16ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146835
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-02
Filing Date
2025-12-01
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076578_001
    Figure TWG2TA001076578_001
  • Figure TWG2TA001076578_002
    Figure TWG2TA001076578_002
  • Figure TWG2TA001076578_003
    Figure TWG2TA001076578_003
Patent Text Reader

Abstract

The present disclosure relates to methods and dosage regimen for treating or preventing a FAP-mediated condition, comprising administering to the subject a compound of Formula (I), as defined herein, or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art